S. Kumar

First name

S.

Last name

Kumar

Pollock, C., Sanchez, J. J. G., Carrero, J. J., Kumar, S., Pecoits-Filho, R., Lam, C. S. P., et al. (2023). Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. Diabet Med, e15200. http://doi.org/10.1111/dme.15200

View

James, G., Sanchez, J. J. G., Carrero, J. J., Kumar, S., Pecoits-Filho, R., Heerspink, H. J. L., et al. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep, 7, 2059-2070. http://doi.org/10.1016/j.ekir.2022.05.033

View

Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., et al. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413

View

Fox, K. M., Pharmd, R. A. G., Bolinder, B., Chen, J., & Kumar, S. (2006). Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002. Clin Ther. http://doi.org/10.1016/j.clinthera.2006.03.005

View

Watson, L., Wilson, B. P., Alsop, J., & Kumar, S. (2011). Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01413.x

View